National Institutes of Health
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, up to $500.0K, closing July 5, 2029.
Overview
This Notice of Funding Opportunity (NOFO) encourages collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools,…